---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-021682"
form_type: "8-K"
ticker: "TNON"
cik: "0001560293"
company_name: "Tenon Medical, Inc."
filed_at: "2026-02-27T23:59:59+00:00"
generated_at: "2026-05-15T23:02:31.499696+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Tenon Medical receives Nasdaq notice of non-compliance with $1.00 minimum bid price; 180-day cure period until Aug 2026

## Summary
- Nasdaq letter dated Feb 25, 2026: common stock failed to maintain $1.00 bid price for 30 consecutive business days.
- Company has until Aug 24, 2026 to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not cured, may qualify for additional 180-day period by meeting other listing standards and intending to reverse split.
- No immediate impact on listing; stock continues to trade under symbol TNON.
- Management is evaluating options, including reverse stock split, to regain compliance.

## SEC filing metadata
- accession: 0001213900-26-021682
- form_type: 8-K
- ticker: TNON
- cik: 0001560293
- company_name: Tenon Medical, Inc.
- filed_at: 2026-02-27T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1560293/000121390026021682/0001213900-26-021682-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1560293/000121390026021682/ea0279079-8k_tenon.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-021682
- JSON: https://secwatch.observer/filing/0001213900-26-021682.json
- Plain text: https://secwatch.observer/filing/0001213900-26-021682.txt

## Source-grounded claims
- claim_id: feab21367110a624618b9568bc4a5f08ee747961
  claim: Tenon Medical, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(b)).
  evidence_excerpt: herein stating that for the 30 consecutive business day period between January 9, 2026 and February 24, 2026, the common stock of the Company had not maintained a minimum closing bid price of $1.00 per share required for continued listing on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided an initial period of 180 calendar days, or until August 24, 2026 (the “Compliance Period”), to regain compliance with the Bid Price Rule. To regain compliance, the closing bid price of the Comp
  evidence_url: https://www.sec.gov/Archives/edgar/data/1560293/000121390026021682/0001213900-26-021682-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.